Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, Natural product-based therapy for acute respiratory distress syndrome: Chitosan inhibits acute lung injury via down regulation of its target gene, 19/April/2015, 18.17, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests, for the first time, that Chitosan, by suppressing the expression of its target gene, it may inhibit acute lung injury. Thereby, it may inhibit the progression of acute respiratory distress syndrome. Thus, pharmacological formulations encompassing “Chitosan or small molecule compounds isolated from Chitosan extract“ may be used to inhibit the progression of acute respiratory distress syndrome.
Amount: $ 300
Undisclosed information: How Chitosan inhibits the progression of acute respiratory distress syndrome
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
